These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 7912895)
1. Regulation of pancreatic tyrosine kinase and phosphatase activities by cholecystokinin and somatostatin. Rivard N; Lebel D; Lainé J; Morisset J Am J Physiol; 1994 Jun; 266(6 Pt 1):G1130-8. PubMed ID: 7912895 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP-1. Douziech N; Calvo E; Coulombe Z; Muradia G; Bastien J; Aubin RA; Lajas A; Morisset J Endocrinology; 1999 Feb; 140(2):765-77. PubMed ID: 9927304 [TBL] [Abstract][Full Text] [Related]
3. Somatostatin inhibits Akt phosphorylation and cell cycle entry, but not p42/p44 mitogen-activated protein (MAP) kinase activation in normal and tumoral pancreatic acinar cells. Charland S; Boucher MJ; Houde M; Rivard N Endocrinology; 2001 Jan; 142(1):121-8. PubMed ID: 11145574 [TBL] [Abstract][Full Text] [Related]
12. CCKA receptor activation stimulates p130(Cas) tyrosine phosphorylation, translocation, and association with Crk in rat pancreatic acinar cells. Ferris HA; Tapia JA; García LJ; Jensen RT Biochemistry; 1999 Feb; 38(5):1497-508. PubMed ID: 9931015 [TBL] [Abstract][Full Text] [Related]
13. Effect of prolonged administration of long-acting somatostatin on caerulein, CCK-8 and GRP induced pancreatic growth in the rat. Hajri A; Aprahamian M; Damgé C Regul Pept; 1991 Feb; 32(2):227-37. PubMed ID: 1709749 [TBL] [Abstract][Full Text] [Related]
14. Somatostatin: a potential antigrowth factor for the exocrine pancreas. Morisset J Regul Pept; 1984 Dec; 10(1):11-22. PubMed ID: 6085177 [TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin rapidly activates mitogen-activated protein kinase in rat pancreatic acini. Duan RD; Williams JA Am J Physiol; 1994 Sep; 267(3 Pt 1):G401-8. PubMed ID: 7943237 [TBL] [Abstract][Full Text] [Related]
16. Defect in pancreatic exocrine and endocrine response to CCK in genetically diabetic OLETF rats. Tachibana I; Akiyama T; Kanagawa K; Shiohara H; Furumi K; Watanabe N; Otsuki M Am J Physiol; 1996 Apr; 270(4 Pt 1):G730-7. PubMed ID: 8928805 [TBL] [Abstract][Full Text] [Related]
17. Dynamics of pancreatic tyrosine kinase and phospholipase D activities in the course of cerulein-induced acute pancreatitis and during regeneration. Rydzewska G; Rivard N; Morisset J Pancreas; 1995 May; 10(4):382-8. PubMed ID: 7792295 [TBL] [Abstract][Full Text] [Related]
18. Co-purification of a protein tyrosine phosphatase with activated somatostatin receptors from rat pancreatic acinar membranes. Zeggari M; Esteve JP; Rauly I; Cambillau C; Mazarguil H; Dufresne M; Pradayrol L; Chayvialle JA; Vaysse N; Susini C Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):441-8. PubMed ID: 7980402 [TBL] [Abstract][Full Text] [Related]
19. Effects of SMS 201-995, a somatostatin analogue, on the exocrine pancreatic secretion and gut hormone release in dogs. Misumi A; Shiratori K; Lee KY; Barkin JS; Chey WY Surgery; 1988 Apr; 103(4):450-5. PubMed ID: 2895501 [TBL] [Abstract][Full Text] [Related]
20. Somatostatin inhibits CCK release by inhibiting secretion and action of CCK-releasing peptide. Herzig KH; Louie DS; Owyang C Am J Physiol; 1994 Jun; 266(6 Pt 1):G1156-61. PubMed ID: 7517637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]